Docoh
Loading...

MDVP Med Spa Vacations

Filed: 22 Jan 21, 10:54am

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the fiscal year ended: September 30, 2020

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the transition period from ___________ to ___________

 

 

Commission file number: 333-210922

 

MED SPA VACATIONS INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

47-5268172

(State or other jurisdiction of incorporation or organization)

 

(IRS Employer Identification No.)

 

23-25 Mangrove Lane, Taren Point, NSW, Australia

(Address of principal executive offices)

 

+61- 1300-488-866

(Registrant s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None 

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None

N/A

N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐     No ☒

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

 

(Note: The registrant is a voluntary filer of reports under Section 13 or 15(d) of the Securities Exchange Act of 1934; the registrant has filed during the preceding 12 months all reports it would have been required to file by Section 13 or 15(d) of the Securities Exchange Act of 1934 if the registrant had been subject to one of such Sections.)

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if this registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ?

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒    No ☐

 

As of January 21, 2021, there were 14,350,000 shares of the registrant’s common stock, par value $0.001 per share, issued and outstanding.

 

 

 

  

MED SPA VACATIONS INC.

 

FORM 10-Q

FOR THE PERIOD ENDED SEPTEMBER 30, 2020

 

TABLE OF CONTENTS 

 

 

 

 

PAGE

 

 

 

 

 

 

 

PART I - FINANCIAL INFORMATION

 

 

 

 

 

 

 

 

Item 1.

Financial Statements (Unaudited)

 

F-1

 

 

 

 

 

 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

3

 

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

6

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

6

 

 

 

 

 

 

 

PART II - OTHER INFORMATION

 

 

 

 

 

 

 

 

Item 1.

Legal Proceedings

 

7

 

 

 

 

 

 

Item 1A.

Risk Factors

 

7

 

 

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

7

 

 

 

 

 

 

Item 3.

Defaults Upon Senior Securities

 

7

 

 

 

 

 

 

Item 4.

Mine Safety Disclosures

 

7

 

 

 

 

 

 

Item 5.

Other Information

 

7

 

 

 

 

 

 

Item 6.

Exhibits

 

8

 

 

 

 

 

 

 

SIGNATURES

 

9

 

 

 
2

Table of Contents

  

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

MED SPA VACATIONS INC.

 

INDEX TO UNAUDITED INTERIM FINANCIAL STATEMENTS

 

FOR THE PERIOD ENDED SEPTEMBER 30, 2020

 

 

Page

 

Unaudited Balance Sheets

 

F-2

 

Unaudited Statements of Operations

 

F-3

 

Unaudited Statements of Stockholders’ Deficit

 

F-4

 

Unaudited Statements of Cash Flows

 

F-5

 

Notes to the Unaudited Financial Statements

 

F-6

 

 
F-1

Table of Contents

 

MED SPA VACATIONS INC.

Balance Sheets

(Unaudited)

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

ASSETS

Current Assets:

 

 

 

 

 

 

Cash

 

$0

 

 

$8,842

 

Total Current Assets

 

 

0

 

 

 

8,842

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$0

 

 

$8,842

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$6

 

 

$9,723

 

Due to related party

 

 

34,322

 

 

 

33,447

 

Total Current Liabilities

 

 

34,328

 

 

 

43,170

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

34,328

 

 

 

43,170

 

 

 

 

 

 

 

 

 

 

Stockholders' Deficit:

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 25,000,000 shares authorized, no shares issued and outstanding

 

 

0

 

 

 

0

 

Common stock, $0.001 par value, 100,000,000 shares authorized, 14,350,000 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively

 

 

14,350

 

 

 

14,350

 

Additional paid-in capital

 

 

272,445

 

 

 

272,445

 

Accumulated deficit

 

 

(321,123)

 

 

(321,123)

Total Stockholders' Deficit

 

 

(34,328)

 

 

(34,328)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

 

$0

 

 

$8,842

 

 

The accompanying notes to the unaudited financial statements are an integral part of these statements.

 

 
F-2

Table of Contents

 

MED SPA VACATIONS INC.

Statements of Operations

(Unaudited)

 

 

 

 Three Months Ended

 

 

 Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Professional fees

 

0

 

 

18,561

 

 

$

0

 

 

$

214,013

 

Total Operating Expenses

 

 

0

 

 

 

18,561

 

 

 

0

 

 

 

214,013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

0

 

 

 

(18,561)

 

 

0

 

 

 

(214,013)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for Income Taxes

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Net Loss

 

$0

 

 

$(18,561)

 

$0

 

 

$(214,013)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share: Basic and Diluted

 

$0

 

 

$(0.00)

 

$0

 

 

$(0.01)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding: Basic and Diluted

 

 

14,350,000

 

 

 

14,350,000

 

 

 

14,350,000

 

 

 

14,350,000

 

 

The accompanying notes to the unaudited financial statements are an integral part of these statements.

 

 
F-3

Table of Contents

 

MED SPA VACATIONS INC.

Statements of Stockholders’ Deficit

(Unaudited)

 

For the Three and Nine Months Ended September 30, 2020

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Common stock

 

 

Paid-in

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

Balance - December 31, 2019

 

 

14,350,000

 

 

$14,350

 

 

$272,445

 

 

$(321,123)

 

$(34,328)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Balance - March 31, 2020

 

 

14,350,000

 

 

 

14,350

 

 

 

272,445

 

 

 

(321,123)

 

 

(34,328)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Balance - June 30, 2020

 

 

14,350,000

 

 

 

14,350

 

 

 

272,445

 

 

 

(321,123)

 

 

(34,328)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Balance - September 30, 2020

 

 

14,350,000

 

 

$14,350

 

 

$272,445

 

 

$(321,123)

 

$(34,328)

 

For the Three and Nine Months Ended September 30, 2019

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Common stock

 

 

Paid-in

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - December 31, 2018

 

 

14,350,000

 

 

$14,350

 

 

$60,255

 

 

$(92,218)

 

$(17,613)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

0

 

 

 

0

 

 

 

(31,610)

 

 

(31,610)

Balance - March 31, 2019

 

 

14,350,000

 

 

 

14,350

 

 

 

60,255

 

 

 

(123,828)

 

 

(49,223)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt forgiveness by former officer

 

 

-

 

 

 

0

 

 

 

212,190

 

 

 

0

 

 

 

212,190

 

Net loss

 

 

-

 

 

 

-

 

 

 

0

 

 

 

(163,842)

 

 

(163,842)

Balance - June 30 2019

 

 

14,350,000

 

 

 

14,350

 

 

 

272,445

 

 

 

(287,670)

 

 

(875)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

0

 

 

 

0

 

 

 

0

 

 

 

(18,561)

 

 

(18,561)

Balance - September 30, 2019

 

 

14,350,000

 

 

$14,350

 

 

$272,445

 

 

$(306,231)

 

$(19,436)

 

The accompanying notes to the unaudited financial statements are an integral part of these statements.

  

 
F-4

Table of Contents

 

MED SPA VACATIONS INC.

Statements of Cash Flow

(Unaudited)

 

 

 

 Nine Months Ended

 

 

 

September 30,

 

 

 

2020

 

 

2019

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

$0

 

 

$(195,452)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Expenses paid by related party

 

 

875

 

 

 

174,290

 

Accounts payable

 

 

(9,717)

 

 

(338)

Net cash used in operating activities

 

 

(8,842)

 

 

(21,500)

 

 

 

 

 

 

 

 

 

Net change in cash for period

 

 

(8,842)

 

 

(21,500)

Cash at beginning of period

 

 

8,842

 

 

 

21,500

 

Cash at end of period

 

$0

 

 

$0

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL CASH FLOW INFORMATION

 

 

 

 

 

 

 

 

Cash paid for income taxes

 

$0

 

 

$0

 

Cash paid for interest

 

$0

 

 

$0

 

 

 

 

 

 

 

 

 

 

NON CASH INVESTING AND FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Related party debt forgiven recorded as additional paid in capital

 

$0

 

 

$212,190

 

 

The accompanying notes to the unaudited financial statements are an integral part of these statements.

 

 
F-5

Table of Contents

 

MED SPA VACATIONS INC.

Notes to the Unaudited Financial Statements

September 30, 2020

 

NOTE 1 – ORGANIZATION, DESCRIPTION OF BUSINESS AND GOING CONCERN

 

We were incorporated in the State of Nevada on October 5, 2015. Our office address is 23-25 Mangrove Lane Taren Point, NSW 2229, Australia.

 

Description of Business

 

Our plan was to develop a business that specializes in marketing health and wellness vacations to both individuals and corporate groups looking to revitalize and develop a fuller day-to-day life. We were looking to establish a niche in the travel market that caters to sustained wellness and rejuvenation, recognizing the ever-increasing social trend toward finding of a more holistic balance in life. We were not successful in our efforts and discontinued that line of business. 

 

Going forward, we intend to seek, investigate and, if such investigation warrants, engage in a business combination with a private entity whose business presents an opportunity for our shareholders. No specific assets or businesses have been definitively identified and there is no certainty that any such assets or business will be identified or that any transactions will be consummated.

 

Going concern and Liquidity Considerations

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of September 30, 2020, the Company has reoccurring losses from operations, an accumulated deficit of $321,123 and has earned no revenues. The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending December 31, 2020.

 

The ability of the Company to emerge from the early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings.

 

These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation of Unaudited Interim Financial Statements

 

The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2020 and the results of operations and cash flows for the periods presented. The results of operations for the period ended September 30, 2020 are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited interim financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on January 5, 2021.

 

 
F-6

Table of Contents

 

Recently Issued Accounting Pronouncements

 

Management has considered all recent accounting pronouncements issued. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited interim financial statements.

 

NOTE 3 – RELATED PARTY TRANSACTIONS

 

During the nine months ended September 30, 2020 and 2019, the Company’s sole Director and Officer paid an amount of $875 and $174,290 by paying for expenses on behalf of the Company, respectively.

 

As of September 30, 2020, and December 31, 2019, there were $34,322 and $33,447 due to related party, respectively.

  

 
F-7

Table of Contents

  

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

Except for historical information, this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements involve risks and uncertainties, including, among other things, statements regarding our business strategy, future revenues and anticipated costs and expenses. Such forward-looking statements include, among others, those statements including the words “expects,” “anticipates,” “intends,” “believes” and similar language. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed herein. You should carefully review the risks described herein and in other documents we file from time to time with the Securities and Exchange Commission. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. We undertake no obligation to publicly release any revisions to the forward-looking statements or reflect events or circumstances after the date of this document.

 

Although we believe that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements.

 

All references in this Form 10-Q to the “Company,” “we,” “us,” or “our,” are to Med Spa Vacations Inc.

 

General Overview

 

We were incorporated in the State of Nevada on October 5, 2015 to develop a business that specializes in marketing health and wellness vacations to both individuals and corporate groups looking to revitalize and develop a fuller day-to-day life. We were not successful in our efforts and discontinued that line of business. Our office address is 23-25 Mangrove Lane, Taren Point, NSW, Australia. Because we were not able to raise sufficient capital to execute our original business plan, we are seeking a business combination with a private entity whose business would present an opportunity for our shareholders.

 

On June 20, 2019, Mr. Ma, closed stock purchase and sale transactions pursuant to which he sold an aggregate of 10,000,000 restricted shares of the Company’s Common Stock, to certain purchasers at a purchase price of $0.035 per share, or an aggregate purchase price of $350,000. In connection with the closing of the stock purchase transactions, Mr. Ma resigned from all of the positions he held with the Company, effective as of the closing of the stock purchase transactions. One of the purchasers of restricted shares, Kynson Health Limited, a BVI entity, purchased 9,985,329 restricted shares for an aggregate purchase price of approximately $349,486. Kynson Health Limited is owned 100% by OuYang XingYing, who was appointed as the Company’s President, Secretary and Treasurer and director on June 20, 2019, upon the closing of the stock purchase and sale transactions and resignation of Mr. Ma.

 

Going forward, we intend to seek, investigate and, if such investigation warrants, engage in a business combination with a private entity whose business presents an opportunity for our shareholders. No specific assets or businesses have been definitively identified and there is no certainty that any such assets or business will be identified or that any transactions will be consummated.

 

We have no revenues and limited cash on hand. We have sustained losses since inception. We have never declared bankruptcy, been in receivership, or involved in any kind of legal proceeding. 

 

 
3

Table of Contents

 

Results of Operations

 

Three-Month Period Ended September 30, 2020 Compared to Three-Month Period Ended September 30, 2019

 

Our results of operations for the three-months ended September 30, 2020 and 2019 are summarized below:

 

 

 

Three Months Ended

 

 

 

September 30,

 

 

 

2020

 

 

2019

 

Revenue

 

$-

 

 

$-

 

Operating expenses

 

 

-

 

 

 

18,561

 

Net loss

 

$-

 

 

$(18,561)

 

Revenues and Other Income

 

During the three months ended September 30, 2020 and 2019, we did not realize any revenues from operations.

 

Operating Expenses

 

Operating expenses consisted entirely of professional fees of $0 in the three months ended September 30, 2020, compared to $18,561 in the three months ended September 30, 2019.

 

Net Losses

 

We incurred a net loss of $0, for the three months ended September 30, 2020, compared to a net loss of $18,561 for the corresponding period ended September 30, 2019.

 

Nine Month Period Ended September 30, 2020 Compared to Nine Month Period Ended September 30, 2019

 

Our results of operations for the nine months ended September 30, 2020 and 2019 are summarized below:

 

 

 

 Nine Months Ended

 

 

 

September 30,

 

 

 

2020

 

 

2019

 

Revenue

 

$-

 

 

$-

 

Operating expenses

 

$-

 

 

$214,013

 

Net loss

 

$-

 

 

$(214,013)

 

Revenues and Other Income

 

During the nine months ended September 30, 2020 and 2019, we did not realize any revenues from operations.

 

Operating Expenses

 

Operating expenses consisted entirely of professional fees of $0 in the nine month period ended September 30, 2020, compared to $214,013 in the nine month period ended September 30, 2019. The professional fess during the nine months ended September 30, 2019 consisted of legal and consulting fees of $151,500 in relation to stock purchase and sale transactions and audit, accounting, tax and other miscellaneous professional fees of $62,513, for getting current on our SEC filing requirements.

 

Net Losses

 

We incurred a net loss of $0, for the nine months ended September 30, 2020, compared to a net loss of $214,013 for the corresponding period ended September 30, 2019.

 

 
4

Table of Contents

 

Liquidity and Capital Resources

 

 

 

September 30,

 

 

December 31,

 

 

 

 

 

2020

 

 

2019

 

 

Change

 

Cash

 

$-

 

 

$8,842

 

 

$(8,842)

Total Assets

 

$-

 

 

$8,842

 

 

$(8,842)

Total Liabilities

 

$34,328

 

 

$43,170

 

 

$(8,842)

Stockholders' Equity

 

$(34,328)

 

$(34,328)

 

$-

 

Working Capital Deficiency

 

$(34,328)

 

$(34,328)

 

$-

 

 

As of the date of this report, we had yet to generate any revenues from our business operations.

 

As of September 30, 2020, we had current assets of $0, we had liabilities of $34,328, and our working capital deficit was $34,328. We anticipate that our current liquidity is not sufficient to meet the obligations associated with being a company that is fully reporting with the SEC.

 

To date, we have managed to keep our monthly cash flow requirement low for two reasons. First, our sole officer does not draw a salary at this time. Second, we have been able to keep our operating expenses to a minimum by operating in space provided at no expense by one of our shareholders.

 

We currently have no external sources of liquidity such as arrangements with credit institutions or off-balance sheet arrangements that will have or are reasonably likely to have a current or future effect on our financial condition or immediate access to capital.

 

Our financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplates our continuation as a going concern. We have not yet generated any revenue and have incurred losses to date of $0. In addition, our current liabilities exceed our current assets by $34,328. These factors raise substantial doubt about our ability to continue operating as a going concern. Our ability to continue our operations as a going concern, realize the carrying value of our assets, and discharge our liabilities in the normal course of business is dependent upon our ability to raise capital sufficient to fund our commitments and ongoing losses, and ultimately generate profitable operations.

 

Cash Flows

 

 

 

 Nine Months Ended

 

 

 

September 30,

 

 

 

2020

 

 

2019

 

Cash used in operating activities

 

$(8,842)

 

$(21,500)

Cash provided by Investing Activities

 

$-

 

 

$-

 

Cash provided by financing activities

 

$-

 

 

$-

 

Net Change In Cash

 

$(8,842)

 

$(21,500)

 

Operating Activities

 

For the nine months ended September 30, 2020, net cash used in operating activities was $8,842, related to our net loss of $0, increased by a decrease in accounts payable of $9,717 and decreased by an increase in expenses paid by related party of $875.

 

For the nine months ended September 30, 2019, net cash used in operating activities was $21,500, related to our net loss of $195,452, reduced by an increase in expenses paid by related party of $174,290, increased by a decrease in accounts payable of $338.

 

During the nine months ended September 30, 2020 and 2019, the Company’s sole Director and Officer paid $875 and $174,290 on behalf of the Company for business operation purpose, respectively.

 

 
5

Table of Contents

 

Investing Activities

 

The Company did not use any funds for investing activities during the nine-months periods ended September 30, 2020 and 2019.

 

Financing Activities

 

The Company did not use any funds for financing activities during the nine-months periods ended September 30, 2020 and 2019.

 

Recent Accounting Pronouncements

 

For a description of our recently issued accounting pronouncements, see “Note 2 – Summary of Significant Accounting Policies” of this Quarterly Report on Form 10-Q.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to select appropriate accounting policies and to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses.

 

Off-Balance Sheet Arrangements

 

We have never entered into any off-balance sheet financing arrangements and have not formed any special purpose entities. We have not guaranteed any debt or commitments of other entities or entered into any options on non-financial assets.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) that are designed to ensure that information required to be disclosed in our Securities Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to our management, as appropriate, to allow timely decisions regarding required disclosure.

 

Our management has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, management has concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were not effective.

 

Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting identified in connection with the evaluation we conducted on the effectiveness of our internal control over financial reporting as of September 30, 2020, that occurred during our first fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 
6

Table of Contents

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We know of no active or pending legal proceedings against us, nor are we involved as a plaintiff in any proceedings or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any beneficial shareholder are an adverse party or has a material interest adverse to us.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Other than as previously reported in our Current Reports on Form 8-K, or prior periodic reports, we did not sell any unregistered securities during the three-month period ended September 30, 2020, or subsequent period through the date hereof.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

 
7

Table of Contents

 

ITEM 6. EXHIBITS

 

The following exhibits are included as part of this report:

 

Exhibit No.

 

Description

 

 

 

31.1 / 31.2 *

 

Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive and Financial and Accounting Officer

32.1 / 32.2 *

 

Rule 1350 Certification of Chief Executive and Financial and Accounting Officer

101.INS *

 

XBRL Instance Document

101.SCH *

 

XBRL Schema Document

101.CAL *

 

XBRL Calculation Linkbase Document

101.DEF *

 

XBRL Definition Linkbase Document

101.LAB *

 

XBRL Label Linkbase Document

101.PRE *

 

XBRL Presentation Linkbase Document

___________

*filed herewith

 

 
8

Table of Contents

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

MED SPA VACATIONS INC.

 

 

 

 

 

Dated: January 22, 2021

By: 

/s/ OuYang XingYing

 

 

Name:

OuYang XingYing

 

 

Title:

President, Treasurer and Secretary

(Principal Executive Officer and Principal Financial and Accounting Officer)

 

 

 
9